Private Advisor Group, LLC
Position in LCTX — Lineage Cell Therapeutics, Inc.
CIK 1567755
MORRISTOWN, NJ
Position in LCTX
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$31,645
-$1,851 QoQ
Shares Held
20,029
-0.1% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LCTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Private Advisor Group, LLC holds $54,215,312 across 44 Biotechnology names. LCTX ranks #41 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,315 | $13,378,261 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
1,648,556 | $12,644,424 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
106,662 | $5,073,911 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,433 | $3,765,671 | |
| 5 | CRMD |
CorMedix Inc.
|
504,668 | $3,426,695 | |
| 6 | TLX |
Telix Pharmaceuticals Ltd
|
174,415 | $1,669,151 | |
| 7 | AVXL |
Anavex Life Sciences Corp.
|
499,700 | $1,534,079 | |
| 8 | CDXS |
Codexis, Inc.
|
847,001 | $1,380,611 |
All Filings in LCTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,645 | 20,029 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $33,496 | 20,058 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $33,898 | 20,058 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $18,252 | 20,058 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $9,026 | 20,058 | Shares | Sole | 2025-05-05 | |
| 2020-06-30 | $57 | 66 | Shares | Sole | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||